Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy: an analysis of the DiaRegis registry - Wasem, Jürgen; Bramlage, Peter; Gitt, Anselm Kai; Binz, Christiane; Krekler, Michael; Deeg, Evelin; Tschöpe, Diethelm (Cardiovascular diabetology, 2013)
Gesehen am 30.09.2021